Rocchi MB - Search Results

1

Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.

Massacesi C, La Cesa A, Marcucci F, Pilone A, Rocchi MB, Zepponi L, Santini D, Tonini G, Burattini L. Massacesi C, et al. Among authors: rocchi mb. Oncology. 2006;70(4):294-300. doi: 10.1159/000096250. Epub 2006 Oct 12. Oncology. 2006. PMID: 17047400 Clinical Trial.

2

Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens.

Massacesi C, Pistilli B, Valeri M, Lippe P, Rocchi MB, Cellerino R, Piga A. Massacesi C, et al. Among authors: rocchi mb. Am J Clin Oncol. 2002 Apr;25(2):140-8. doi: 10.1097/00000421-200204000-00008. Am J Clin Oncol. 2002. PMID: 11943891

3

Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.

Mazzanti P, Massacesi C, Rocchi MB, Mattioli R, Lippe P, Trivisonne R, Buzzi F, De Signoribus G, Tuveri G, Rossi G, Di Lullo L, Sturba F, Morale D, Catanzani S, Pilone A, Bonsignori M, Battelli T. Mazzanti P, et al. Among authors: rocchi mb. Lung Cancer. 2003 Jul;41(1):81-9. doi: 10.1016/s0169-5002(03)00140-5. Lung Cancer. 2003. PMID: 12826316 Clinical Trial.

4

Raltitrexed-induced hepatotoxicity: multivariate analysis of predictive factors.

Massacesi C, Santini D, Rocchi MB, La Cesa A, Marcucci F, Vincenzi B, Delprete S, Tonini G, Bonsignori M. Massacesi C, et al. Among authors: rocchi mb. Anticancer Drugs. 2003 Aug;14(7):533-41. doi: 10.1097/00001813-200308000-00005. Anticancer Drugs. 2003. PMID: 12960737 Clinical Trial.

5

Serum tumor markers may precede instrumental response to chemotherapy in patients with metastatic cancer.

Massacesi C, Rocchi MB, Marcucci F, Pilone A, Galeazzi M, Bonsignori M. Massacesi C, et al. Among authors: rocchi mb. Int J Biol Markers. 2003 Oct-Dec;18(4):295-300. doi: 10.5301/jbm.2008.3624. Int J Biol Markers. 2003. PMID: 14756546 Free article.

6

Factors predicting docetaxel-related toxicity: experience at a single institution.

Massacesi C, Marcucci F, Rocchi MB, Mazzanti P, Pilone A, Bonsignori M. Massacesi C, et al. Among authors: rocchi mb. J Chemother. 2004 Feb;16(1):86-93. J Chemother. 2004. PMID: 15078005 Clinical Trial.

7

High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer.

Mattioli R, Massacesi C, Recchia F, Marcucci F, Cappelletti C, Imperatori L, Pilone A, Rocchi M, Cesta A, Laici G, Bonsignori M, Lippe P. Mattioli R, et al. Ann Oncol. 2005 Jul;16(7):1147-51. doi: 10.1093/annonc/mdi222. Epub 2005 Apr 22. Ann Oncol. 2005. PMID: 15849224 Free article. Clinical Trial.

8

Low dose-intensity docetaxel in the treatment of pre-treated elderly patients with metastatic breast cancer.

Massacesi C, Marcucci F, Boccetti T, Battelli N, Pilone A, Rocchi MB, Bonsignori M. Massacesi C, et al. Among authors: rocchi mb. J Exp Clin Cancer Res. 2005 Mar;24(1):43-8. J Exp Clin Cancer Res. 2005. PMID: 15943030 Clinical Trial.

9

Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy.

Massacesi C, Terrazzino S, Marcucci F, Rocchi MB, Lippe P, Bisonni R, Lombardo M, Pilone A, Mattioli R, Leon A. Massacesi C, et al. Among authors: rocchi mb. Cancer. 2006 Mar 1;106(5):1007-16. doi: 10.1002/cncr.21722. Cancer. 2006. PMID: 16456808 Free article. Clinical Trial.

10

Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.

Catalano V, Bergamo F, Cremolini C, Vincenzi B, Negri F, Giordani P, Alessandroni P, Intini R, Stragliotto S, Rossini D, Borelli B, Santini D, Sarti D, Rocchi MBL, Lonardi S, Falcone A, Zagonel V, Mattioli R, Graziano F. Catalano V, et al. J Cancer Res Clin Oncol. 2020 Feb;146(2):493-501. doi: 10.1007/s00432-019-03077-w. Epub 2019 Nov 6. J Cancer Res Clin Oncol. 2020. PMID: 31691872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters